Key result
Cd72(B6) transgenic mice, but not Cd72(B6/MRL) transgenic mice, showed a significant reduction in mortality and marked improvement of lupus disease.
The Cd72 polymorphism in the membrane-distal extracellular domain affects susceptibility to lupus phenotypes, including glomerulonephritis and vasculitis, in a mouse model.
Animal lupus findings should not guide clinical care; leaves open Cd72 variant effects on human SLE.
Systemic lupus erythematosus is considered to be under the control of polygenic inheritance, developing according to the cumulative effects of susceptibility genes with polymorphic alleles; however, the mechanisms underlying the roles of polygenes based on functional and pathological genomics remain uncharacterized. In this study, we substantiate that a CD72 polymorphism in the membrane-distal extracellular domain impacts on both the development of glomerulonephritis and vasculitis in a lupus model strain of mice, MRL/MpJ-Fas(lpr), and the reactivity of BCR signal stimulation. We generated mice carrying a bacterial artificial chromosome transgene originating from C57BL/6 (B6) mice that contains the Cd72(b) locus (Cd72(B6) transgenic [tg]) or the modified Cd72(b) locus with an MRL-derived Cd72(c) allele at the polymorphic region corresponding to the membrane-distal extracellular domain (Cd72(B6/MRL) tg). Cd72(B6) tg mice, but not Cd72(B6/MRL) tg mice, showed a significant reduction in mortality following a marked improvement of disease associated with decreased serum levels of IgG3 and anti-dsDNA Abs. The number of splenic CD4(-)CD8(-) T cells in Cd72(B6) tg mice was decreased significantly in association with a reduced response to B cell receptor signaling. These results indicate that the Cd72 polymorphism affects susceptibility to lupus phenotypes and that novel functional rescue by a bacterial artificial chromosome transgenesis is an efficient approach with wide applications for conducting a genomic analysis of polygene diseases.
No takes yet. Share an insight, caveat, or question.
Oishi et al. (2013) studied Systemic lupus erythematosus. Cd72(B6) transgene vs. Cd72(B6/MRL) transgene was evaluated on Mortality and disease improvement. Cd72(B6) transgenic mice, but not Cd72(B6/MRL) transgenic mice, showed a significant reduction in mortality and marked improvement of lupus disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: